Easun Capital Ma (542906)
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹43.16 |
| Market Cap | ₹22.57 Cr |
| P/E Ratio | 103 |
| ROCE | 0.55% |
| ROE | 1.13% |
| Dividend Yield | 0% |
| Profit Growth | -21.74% |
| Debt/Equity | — |
| Sales Growth | -18.42% |
| 52-Week Range | ₹33.21 — ₹57.38 |
| Sector | Finance |
| Book Value | ₹43.96 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
At ₹43.16, I am being asked to pay almost exactly the stated book value of ₹43.96. That sounds like Graham's margin of safety, but the rest of the story does not support it. A P/E of 103 with earnings shrinking 21.74% tells me this is not a compounding machine. ROE is just 1.13%, and ROCE only 0.55% — the capital in this business is earning almost nothing. In fact, a fixed deposit would beat it. Sales fell 18.42%, and the latest quarter shows zero sales and zero profit. That is not a company generating value; it is a shell with a book value. This looks like an asset play, not a business. I would only be interested if the book value is real, liquid, and can be unlocked by management. But with a Piotroski F-Score of 3/9, the financial health is weak. There is no dividend, so shareholders receive no income while they wait. Market cap is just ₹23 crore, so there is a possibility that assets could be sold or capital returned, but I cannot rely on that hope. In Buffett's world, a fair price for a poor business can still be a bad investment. I would demand a meaningful discount to a conservatively calculated book value and evidence that management is serious about creating value. Without that, this is a pass.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer